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Abstract
The killing of bacterial pathogens by macrophages occurs via the oxidative burst and bacteria have evolved to overcome
this challenge and survive, using several virulence and defense strategies, including antioxidant mechanisms. We show here
that the 1-Cys peroxiredoxin LsfA from the opportunistic pathogen Pseudomonas aeruginosa is endowed with thiol-
dependent peroxidase activity that protects the bacteria from H2O2 and that this protein is implicated in pathogenicity. LsfA
belongs to the poorly studied Prx6 subfamily of peroxiredoxins. The function of these peroxiredoxins has not been
characterized in bacteria, and their contribution to host-pathogen interactions remains unknown. Infection of macrophages
with the lsfA mutant strains resulted in higher levels of the cytokine TNF-a production due to the activation of the NF-kB
and MAPK pathways, that are partially inhibited by the wild-type P. aeruginosa strain. A redox fluorescent probe was more
oxidized in the lsfA mutant-infected macrophages than it was in the macrophages infected with the wild-type strain,
suggesting that the oxidative burst was overstimulated in the absence of LsfA. Although no differences in the phagocytosis
rates were observed when macrophages were infected with wild-type and mutant bacteria in a gentamicin exclusion assay,
a higher number of wild-type bacterial cells was found in the supernatant. This difference was not observed when
macrophages were pre-treated with a NADPH oxidase inhibitor, confirming the role of LsfA in the bacterial resistance to ROS
generated via NADPH oxidase. In an acute pneumonia model, mice infected with the mutant strains presented higher
cytokine release in the lungs and increased activated neutrophil recruitment, with reduced bacterial burden and improved
survival rates compared to mice infected with the wild-type bacteria. LsfA is the first bacterial 1-Cys Prx shown to modulate
host immune responses and its characterization will allow a better understanding of the role of redox signaling in host-
pathogen interactions.
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Introduction
Pseudomonas aeruginosa is a ubiquitous Gram-negative bacte-
rium that can cause diseases in several hosts [1]. P. aeruginosa
acute infections are one of the major problems in immunodeficient
subjects, burn victims and mechanical ventilation patients.
Pulmonary infections caused by P. aeruginosa, including ventila-
tor-associated pneumonia and chronic pulmonary infection in
cystic fibrosis patients, are associated with high mortality rates, and
chronic pulmonary infection impairs life quality and life expec-
tancy of the infected individuals [2–4]. The high intrinsic
resistance of P. aeruginosa to antibiotics adds to the difficulties
of treating infections caused by this versatile opportunist [5].
Macrophages are the first line of defense in pulmonary
infections and play a major role in the host response to P.
aeruginosa infections. Pathogens are recognized by the immune
system, which detects pathogen-associated molecular patterns
(PAMPs) by the corresponding pattern recognition receptor. The
activation of signaling cascades by the binding of PAMPs to Toll-
like receptors (TLRs), except for TLR-3, depends on MyD88 and
results in the activation of the NF-kB and MAPK pathways [6];
their activation leads to the production of cytokines, including
TNF-a, IL-6 and IL-1. The role of TLR-4 and TLR-5 in
triggering a protective immunity against P. aeruginosa has been
shown in vivo; as mice lacking TLR-4/5 have increased
susceptibility to pulmonary infections [7,8].
After the recognition of bacteria by the TLRs in macrophages,
the signaling cascade leads to the generation of reactive oxygen
species (ROS) in a process known as the oxidative burst, which
depends on NADPH oxidase [9]. The oxidative burst is
bactericidal and can cause lipid, protein and DNA lesions,
resulting in pathogen clearing. However, to overcome or prevent
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these lesions, pathogens have developed a complex detoxification
system that includes superoxide dismutase, and catalase/peroxi-
dases that have been extensively studied in several pathogens,
including P. aeruginosa [10,11].
Among hydroperoxide-reducing enzymes, the peroxiredoxins
(Prxs) are considered cellular sensors due to their abundance and
reactivity [12]. Prxs catalyze the reaction ROOH+2e2RROH+
H2O and reduce hydrogen peroxide, peroxynitrite and a wide
range of organic hydroperoxide compounds [13–15]. Prxs are
found in organisms belonging to all Domains of life, indicating
their crucial physiological function, but their role in P. aeruginosa
virulence remains uncharacterized.
Prxs are a large family of proteins that can be divided into six
sub-groups with distinct amino acid sequences, but all contain the
thioredoxin fold and the PXXT(S)XXC motif [16]. Among these
six-subgroups, Prx enzymes can display 2-Cys Prx or 1-Cys-Prx
mechanisms, depending on the number of cysteine residues
involved in catalysis [16]. AhpC, a 2-Cys Prx, is involved in the
virulence of Helicobacter cinaedi and Staphylococcus aureus
[17,18], but it does not seem to be a virulence determinant for
other bacteria that have been analyzed [19–21].
The genome of the highly virulent P. aeruginosa strain PA14
contains at least eight genes that encode Prxs, including AhpC and
Tpx. Ohr is another Cys-based peroxidase from P. aeruginosa
that has been structurally and enzymatically characterized [22],
but it is not required for virulence [23].
Among the six Prx sub-groups, Prx6 is the least well studied.
The precise physiological roles of the Prx6 sub-group remain
unknown, with few reports addressing their kinetics and structural
functions; most of these reports were from studies of eukaryotes
[24–29]. Thus far, all of the Prx6 proteins characterized display
the 1-Cys Prx mechanism. Remarkably, although the bacterial
Domain contains hundreds of Prx6 representatives [16], no
characterization of their roles has been reported.
In the P. aeruginosa genome, only one gene coding for a putative
Prx6 is present (PA14_19490 in PA14; PA3450 in PA01). It was named
lsfA because its expression is up-regulated, together with a gene cluster
coding for an ABC-transport system involved in organic sulfur uptake,
in cells grown in low-sulfate medium [30]. However, there is no
experimental evidence for the mechanism underlying the function of
LsfA in this process. It has been suggested that LsfA up-regulation and
AhpC expression in low sulfate conditions may be a response to the
oxidative stress caused by the excess levels of reduced flavin nucleotides
due to sulfonate utilization [31]. Several transcriptomic analyses have
revealed that lsfA expression is up-regulated in other stressful
conditions, including in the presence of sodium hypochlorite [32], a
product of the macrophage oxidative burst. Proteomic analyses
identified LsfA as differentially expressed during other stressful
conditions. Three LsfA isoforms are induced by the superoxide-
generating drug paraquat [33] and in P. aeruginosa biofilms [34]. In
iron starvation conditions, Pseudomonas putida also showed increased
levels of the LsfA ortholog protein [35]. Interestingly, indole treatment,
which may mimic conditions of iron abundance, decreased lsfA
expression as well as virulence-related traits [36]. A more recent report
found that the oxidation responsive OxyR activator protein binds to
the lsfA promoter region [37]; this observation supports the role of
LsfA in the bacterial response to H2O2.
Here, we show that the antioxidant function of the bacterial 1-Cys
Prx LsfA is important for P. aeruginosa virulence, both in a
macrophage model in vitro and in an acute pneumonia model in
vivo. This work reveals the role of this protein as a novel virulence
factor that contributes to the P. aeruginosa arsenal against host
defenses and allows it address other stresses in various environmental
conditions.
Results
LsfA is an active peroxiredoxin and is important for the
antioxidant response
A previous sequence alignment revealed that LsfA belongs to
the Prx6 subfamily [16], with the Cys45 of LsfA as the putative
peroxidasic cysteine (Fig. S1). To determine whether P. aerugi-
nosa LsfA is indeed endowed with thiol-dependent peroxidase
activity, the recombinant wild-type (His-LsfA) protein and a
mutant protein without the putative catalytic cysteine (His-C45A)
were expressed in Escherichia coli and purified by affinity
chromatography. As predicted, H2O2 was reduced in the presence
of wild-type His-LsfA but not when His-C45A was employed
(Fig. 1A), showing that Cys45 is essential for catalysis and
confirming that LsfA is an active 1-Cys Prx.
Because 2-Cys Prxs play an important role in bacterial
protection against H2O2, tert-butyl hydroperoxide and paraquat
[13,14], we assessed whether LsfA was also important for P.
aeruginosa resistance to such oxidants. To test this hypothesis, an
in-frame deletion mutant strain (DlsfA) and a strain with a point
mutation in the catalytic cysteine (C45A) were constructed. Both
mutant strains grow like wild-type in minimal medium and in
biofilms, excluding any growth defects (Fig. S2). The wild-type,
DlsfA and C45A strains were tested using disk diffusion halo assays
in the presence of oxidants. Larger inhibition haloes due to H2O2
were observed for both mutant strains (12.860.7 mm for DlsfA,
13.060.6 mm for C45A) compared with PA14 (7.460.8 mm for
PA14) (Fig. 1B), indicating that LsfA is important for oxidative
stress resistance in P. aeruginosa and confirming that the C45
catalytic cysteine is essential for LsfA activity. Complementation of
the mutant strains with a copy of the lsfA gene in a plasmid
restored the wild-type phenotype (Fig. S3), confirming that the
larger haloes were due to a lack of LsfA activity. The lsfA mutants
did not demonstrate increased sensitivity to paraquat or tert-butyl
hydroperoxide (data not shown), which may reflect a compensa-
tory effect of other Prxs and/or Ohr.
LsfA is required for the inhibition of macrophage
activation by P. aeruginosa
Because macrophages and neutrophils produce ROS and
reactive nitrogen species in response to pathogens, bacterial
Author Summary
Pseudomonas aeruginosa is an important human pathogen
that employs a vast arsenal of virulence factors and infects
immunocompromised hosts, such as patients in intensive
care units, causing pneumonia and other illnesses.
Macrophages are cells in the first line of defense against
pathogens in the lungs. After pathogen recognition,
macrophages release pro-inflammatory cytokines to re-
cruit other immune cells and employ a process known as
oxidative burst to kill invading microbes. P. aeruginosa can
counteract oxidative stress using antioxidant proteins,
such as peroxiredoxins. We show here that LsfA, which
belongs to the poorly characterized Prx6 subfamily of
peroxiredoxins, is indeed endowed with a thiol-dependent
activity that is required for full virulence. In vitro and in vivo
infection models confirmed that LsfA peroxidase activity is
required for the immunomodulation caused by P. aerugi-
nosa and that its absence allows the host to overcome the
infection. This study demonstrates for the first time the
involvement of a bacterial Prx6 in virulence.
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antioxidant systems are important mechanisms that allow bacteria
to overcome the deleterious effects of oxidative lesions and to
survive during infection. To assess whether the P. aeruginosa LsfA
is related to virulence, an in vitro model of infection in J774
macrophages was used. The macrophages were infected with
PA14 and the lsfA mutants, and incubated for 1 hour prior to the
gentamicin addition. At regular time points, the number of
bacterial cells remaining in the culture supernatants was assessed
(Fig. 2A), the macrophages were washed and lysed, and the
released bacteria were counted (Fig. 2B). The phagocytosed
bacteria counts were similar for all strains and showed a slight
increase over time (Fig. 2B), suggesting that all of the strains were
internalized by macrophages at the same extent. However, for the
lsfA mutants, a 2-fold reduction in extracellular colony-forming
units (CFUs) compared with the wild-type PA14 was observed
(Fig. 2A). Thus, the peroxidase activity of LsfA contributes to
bacterial viability in the presence of macrophages. The number of
remaining macrophages at the end of the assay, assessed by a LDH
release assay, was similar for all bacterial strains tested, showing
that LsfA does not alter cytotoxicity (Fig. S4).
The increased survival of PA14 compared with the lsfA mutants
may reflect a change in the oxidative status of the macrophages in
addition to an improved bacterial response to the oxidative burst.
To address this hypothesis, macrophages were incubated with
wild-type or mutant strains, and at different times, the cells were
washed and incubated with 29,79-dichlorodihydrofluorescein
diacetate (H2DCFDA), a probe that can sense shifts in the cellular
redox state. After 3 hours of treatment, an increase in the
intracellular oxidative status in macrophages incubated with the
lsfA mutant strains was observed, in comparison with macro-
phages infected with PA14 (Fig. 3A). This result suggests that LsfA
participates in the response of P. aeruginosa to the oxidative insult
caused by the macrophages, most likely due to its peroxidase
activity. Because LsfA affects the macrophage redox status, it can
also impact virulence by subverting the host signaling pathways
[38]. The mutant for gacA, which encodes a protein that plays a
Figure 1. LsfA confers PA14 resistance to hydrogen peroxide
and reduces it in vitro. (A) The recombinant proteins His-LsfA and
His-C45A were incubated with 200 mM H2O2. The amount of H2O2
remaining in the reaction mixtures was determined by ferric-
thiocyanate assays at the indicated time points. In a control assay,
H2O2 was incubated with buffer without recombinant proteins. The
data are the means 6 SD from at least three independent experiments
performed in triplicate. (B) Bacteria were grown to an OD600 nm of 1 and
spread on LB plates. A 6 mm filter disk containing 2.5% H2O2 was
placed on top of the bacterial lawn, and the plates were incubated at
37uC for 16 hours. The data represent 1 of 5 independent experiments
and the diameters of the inhibition haloes are shown as the means 6
SD (mm).
doi:10.1371/journal.ppat.1004442.g001
Figure 2. The lsfA mutants are phagocytosed at the same rate
as PA14, but do not survive as well as PA14 in the cultures
supernatants. J774 macrophages were incubated with P. aeruginosa
PA14 or the DlsfA or C45A mutants at an MOI of 10. (A) At the indicated
time points, the supernatants were collected and diluted, and the
number of CFU was determined. (B) The cells were washed with PBS
and R-10 containing 200 mg/mL gentamicin was added to the wells. At
the indicated time points, the macrophages were lysed with Triton X-
100. The released bacteria were diluted, and number of CFU was
determined. The data shown are the means 6 SD from at least three
independent experiments performed in triplicate. *, p,0.05.
doi:10.1371/journal.ppat.1004442.g002
1-Cys Peroxiredoxin in Bacterial Virulence
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role in P. aeruginosa pathogenicity, has been extensively studied
[39] and caused a similar increase in the macrophage oxidative
state (Fig. 3A), suggesting that LsfA may indirectly inhibit the
oxidative burst.
To evaluate the role of ROS generated by NADPH oxidase in
the clearance of lsfA mutant strains, a gentamicin exclusion assay
was performed again with macrophages, now pre-treated with
DPI, a NADPH oxidase inhibitor. The CFU number correspond-
ing to the bacteria that survive inside the DPI-treated macro-
phages is higher than in untreated ones (Fig. 2B and 3B),
suggesting that they are no longer able to kill the bacteria.
Moreover, the number of PA14 or the mutant cells under DPI
treatment were similar both intra and extracellular, suggesting that
LsfA counteracted NADPH oxidase activity during PA14 evasion
from the macrophages (Fig. 3B and C). To understand whether P.
aeruginosa LsfA modulates macrophage activation, J774 cells were
infected with PA14 or the lsfA mutant strains. The supernatants
were recovered after 3 hours, and cytokine levels were measured.
Macrophages infected with the lsfA mutants secreted more TNF-a
than macrophages infected with PA14 (Fig. 3D). This result
suggests that the LsfA function decreases macrophage activation
and, thus, its oxidative state because the oxidative burst is less
pronounced when macrophages are infected with the wild-type
strain.
C45A-infected macrophages treated with the thiol-reductant N-
acetylcysteine (NAC) showed a reduced oxidative state (Fig. S5)
and lower TNF-a production, similar to that of PA14-infected
macrophages either in the presence or absence of NAC (Fig. 3D).
Both NAC and LsfA may prevent macrophage activation by
decreasing the oxidative state of phagocyte and thereby subverting
signaling pathways involved in the immunological response.
Indeed, ROS can act as signaling molecules that lead to NF-kB
and MAPK activation and increased cytokine production [40]. To
determine which signaling pathways are up-regulated when the
macrophages are infected with lsfA mutant strains, specific
inhibitors of NF-kB or the MAPKs ERK1/2, JNK or p38 were
used. In the presence of these inhibitors, no differences in TNF-a
production were observed when macrophages were infected with
either PA14 or C45A strains (Fig. 3D). These data suggest that
LsfA peroxidase activity in PA14 decreases the activation of the
NF-kB and MAPK pathways, and this decreased activation is
reflected in the lower oxidative state of macrophages.
Figure 3. LsfA downregulates macrophages oxidative state that protected the bacteria against NADPH oxidase-generated ROS,
and inhibits TNF-a production via the MAPK and NF-kB pathways. (A) J774 cells were infected with PA14 or the DlsfA, C45A, or gacA
mutants. After 1, 2 or 3 hours, the macrophages were washed with PBS and incubated for 15 min with H2DCFDA. Fluorescence was analyzed by
FACS. (B) Macrophages were treated with DPI prior to infection. The supernatants were collected and diluted at the indicated time points, and the
number of CFU was determined. (C) Cells were washed with PBS and R-10 containing 200 mg/mL gentamicin was added to the wells. At the indicated
time points, the macrophages were lysed with Triton X-100. The released bacteria were diluted and number of CFU was determined (D) Macrophages
were infected with PA14 or the lsfA mutants in the absence (-) or the presence of inhibitors of NF-kB (BAY11-7580), ERK (U0126), JNK (SP600125) and
p38 (SB2035-80) or the antioxidant N-acetylcysteine (NAC). After 3 hours of infection, the supernatants were recovered, and TNF-a secretion was
determined by ELISA. Data are the means 6 SD from three independent experiments performed in triplicate. *, p,0.05; ***, p,0.001.
doi:10.1371/journal.ppat.1004442.g003
1-Cys Peroxiredoxin in Bacterial Virulence
PLOS Pathogens | www.plospathogens.org 4 October 2014 | Volume 10 | Issue 10 | e1004442
LsfA is essential for P. aeruginosa full virulence in vivo
Because LsfA is required for virulence in macrophages in vitro,
the next step was to ascertain whether this 1-Cys Prx belonging to
Prx6 group was also relevant in an acute pneumonia model in
mice. Although all mice infected intratracheally (i.t.) with PA14
were dead 48 hours after infection, mice infected with lsfA strains
had higher survival rates, with 37.5% of animals still alive after 13
days (Fig. 4A). After 60 days, surviving mice that had previously
been infected with DlsfA (37.5%) and C45A (25%) seemed
healthy, indicating that the infection had resolved or became
chronic. In conclusion, the requirement of LsfA activity for P.
aeruginosa virulence was confirmed.
P. aeruginosa introduced i.t. into mice disseminates quickly and
affects other organs, leading to death [8]. Bacterial loads were
assessed in the primary site of infection as well as in secondary
organs (liver and spleen) as an indication of sepsis. Lungs, spleen
and liver were recovered 24 hours p.i., and bacterial counts were
evaluated. Animals infected with the C45A mutant strain showed
a reduced bacterial burden in all organs analyzed compared with
PA14-infected animals (Fig. 4B). This result indicates an improved
bacterial resolution in mice infected with the C45A strain and
demonstrates the relevance of the 1-Cys Prxs to virulence.
To ascertain whether LsfA would impact cytokine production in
vivo, thus potentially decreasing the immune system activation and
neutrophil recruitment to the infection site, the TNF-a and IFN-c
levels in the lungs of infected animals were determined by ELISA
at 24 hours p.i. The wild-type strain induced local immunosup-
pression, with TNF-a and IFN-c release similar to that observed in
the control mice (Fig. 4C). However, mice infected with C45A
released higher levels of these cytokines (Fig. 4C). No differences
were observed in the anti-inflammatory cytokine IL-10 in mice
infected with either PA14 or the lsfA mutant strain compared to
the control (Fig. S6). In addition, C45A-infected mice showed an
increased recruitment of neutrophils (Ly6G/Ly6C+; F4/802) and
macrophages (F4/80+; CD11b+) to the lungs compared with the
controls (Fig. 4D). To determine if the recruited neutrophils were
activated, myeloperoxidase (MPO) activity was present in all
treatments, but it was higher when mice were infected with the
C45A mutant strain (Fig. 4E), suggesting that thiol peroxidase
activity is also involved in neutrophil activation. This set of data
confirms that a better immune response that is reflected in the
higher survival of the lsfA mutant-infected animals compared to
those infected with PA14.
Discussion
In this study, we show for the first time the relevance of the 1-
Cys Prx LsfA in bacterial virulence. LsfA, a Prx from P.
aeruginosa, is the first protein in the Prx6 sub-group to be
connected to pathogenicity. This protein, LsfA, has orthologues in
other pathogens, including Burkholderia and Bordetella, suggest-
ing that this host-pathogen interaction may be present in other
bacteria. Biochemical analysis demonstrated that LsfA has
peroxidase activity that depends on the catalytic cysteine (C45).
Inactivating this peroxidase activity makes lsfA mutant cells more
Figure 4. LsfA plays an important role in virulence in an acute pneumonia model. (A) BALB/c mice were infected i.t. with 26106 bacteria
per mouse with wild-type strain PA14 or the DlsfA or C45A mutants (n = 8 per group). Control mice were inoculated with PBS (n = 3) and the survival
of the mice was followed for the course of the experiment. (B) At 24 hours post-infection, three animals were sacrificed, the organs were macerated,
and the bacterial CFU were enumerated. (C) The cytokines in the lungs were determined by ELISA. (D) Mice were infected with PA14 or the C45A
mutant. At 24 hours post-infection, the animals were euthanized, and the lungs were macerated. The cell suspensions were labeled for macrophages
(F4/80+; CD11b+) or neutrophils (Ly6G/Ly6C+; F4/802) and analyzed by FACS. (E) Mice were infected with PA14 or the C45A mutant. At 24 hours post-
infection, the animals were euthanized, and the lungs were macerated, the cells were lysed by sonication and the suspension was centrifuged. The
resulting supernatant was used for MPO activity assay with TMB., and OD was measured at 450 nm. The data are representative of three (B, C) or two
(D, E). independent experiments independent experiments *, p,0.05; **, p,0.01; ***, p,0.001.
doi:10.1371/journal.ppat.1004442.g004
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sensitive than wild-type cells to hydrogen peroxide but not to
organic peroxides, including tert-butyl-hydroperoxide. In addition,
LsfA may also be endowed with other enzymatic activity because
LsfA displays a conserved lipase motif (GDSWG) that is also
present in the Prx6 from humans and mice. Curiously, the lipase
motif is not conserved in all 1-Cys Prxs, and a deeper analysis of
the evolution and function of 1-Cys Prxs is in progress. However,
the lipase motif is not required for virulence in the mice
macrophage and lung models we used here, as a point mutation
in the catalytic cysteine was sufficient to abrogate the virulence to
the same extent as when the entire lsfA coding region was deleted
from the P. aeruginosa chromosome. Prx proteins have been
implied in several diseases in humans. The 1-Cys Prdx6 has been
characterized as a tumor inhibitor because it protects mice and
human skin cells against lipid peroxidation [41], and the levels of
this protein are lower in papillary thyroid carcinomas than in
normal thyroid tissue [42]. Prx6 may also be involved in
degenerative neuronal disorders, including Alzheimer’s disease
and prion diseases [43,44]. In mice infected i.t. with P. aeruginosa,
LsfA directly or indirectly downregulates the host innate immune
response, enabling the pathogen to spread and colonize other
organs, leading to an acute infection that results in death. In the
macrophage infection model, LsfA is required for P. aeruginosa
resistance to clearance, with lower TNF-a production in
macrophages infected with the PA14 strain compared with
macrophages infected with lsfA mutants, suggesting that LsfA
plays a role in the PA14 immunomodulatory effect. This
immunomodulation seems to be related to the macrophages’
oxidative state, which is higher when the macrophages are infected
with lsfA mutant strains than when they are infected with the wild-
type PA14. We also found that NADPH oxidase activity is
required for the clearance of the lsfA mutant, indicating that LsfA
is important for PA14 resistance to ROS generated by macro-
phages. Other P. aeruginosa virulence factors also promote
immunomodulation. ExoU, a secreted phospholipase, inhibits
caspase-1 activation, which is related to pro-IL-1b maturation
[45]. The quinolones HHQ and PQS can also negatively regulate
the immune system, reducing NF-kB activation, bacterial clear-
ance and TNF-a and IL-6 production [46]. Nevertheless, this is
the first evidence of a Prx exerting an immunomodulatory
function, protecting the pathogen against phagocytes, reducing
phagocyte activation and leading to increased bacterial virulence.
We also found that the oxidation of H2DCFDA was higher in
macrophages infected with lsfA mutant strains than in macro-
phages infected with PA14. In support to our findings, LPS
stimulated macrophages, carrying a knockout of the 2-Cys PrxII
gene, released more pro-inflammatory cytokines, including TNF-a
and IL-6, than wild-type macrophages. This increase in cytokine
release is correlated with higher ROS production by the PrxII
knockout macrophages, leading to activation of the MAPK and
NF-kB pathways [47]. In this study, we show that the lack of a
bacterial Prx seems to have the same effect as the lack of PrxII in
macrophages, and we speculate that a balance between ROS
production and turnover might be necessary to allow the outcome
of a host-pathogen interaction to swing from an efficient immune
response to virulence, favoring either the host or the bacteria.
In addition to bactericidal activity, ROS can also act as
signaling molecules, but the mechanisms involved are poorly
understood. Further studies are required to investigate how
oxidative stress leads to NF-kB and MAPK activation. However,
it appears that bacterial antioxidants play a role in protecting
microorganisms from oxidative insult [38] and subvert signaling
pathways such as those involved in the immunological response
[48].
With the increasing resistance of pathogens to antibiotics, it is
crucial to explore new paradigms to develop novel anti-infective
drugs, taking advantage of a deeper understanding of bacterial
virulence and host defense mechanisms. One aspect that may be
explored to achieve this goal is the ROS sensing and production
that is employed by both pathogens and hosts. Understanding the
role of LsfA in the P. aeruginosa immunomodulatory effect may
lead to novel therapeutics to overcome the effects of infection by
targeting LsfA itself or by improving the host immune response.
Methods
Bacterial strains, plasmids, oligonucleotides and culture
conditions
All of the strains and plasmids used in this study are listed in
Supporting Table S1. The P. aeruginosa strains were grown at
37uC in LB broth. The E. coli strains were grown in LB
supplemented with 100 mg/mL of ampicillin, 50 mg/mL of
kanamycin, or 10 mg/mL of gentamicin, when required. The P.
aeruginosa strains were grown in 250 mg/mL of kanamycin,
20 mg/mL nalidixic acid or 30 mg/mL of gentamicin, when
required.
To construct the unmarked in-frame deletion of lsfA, primers
flanking the upstream and downstream regions of lsfA were
designed. Amplicons were cloned into pNPTS138 at the HindIII
and EcoRI sites to generate pNPTS138DlsfA. The resulting
construct was used to introduce the lsfA deletion into the wild-type
PA14 genome by homologous recombination [49], resulting in the
DlsfA mutant, that contains only the first eight N-terminal
aminoacids and 31 aminoacids at the LsfA C-terminus. No polar
effect is expected, because lsfA coding region is distant 249 bp
from the next open reading frame in the PA14 genome and the
frame of translation was maintained.
The oligonucleotide-directed mutagenesis of the LsfA Cys45 to
Ala was performed using the primer pairs listed in Supporting
Table S2, and a two-step procedure was performed as previously
described [50]. The resulting amplicon was cloned into
pNPTS138 and introduced into the PA14 genome by homologous
recombination. Mutant clones were screened by PCR followed by
digestion or direct sequencing. Again, no polar effects are
anticipated, because only one codon was changed.
To construct the lsfA complementation strains, the lsfA coding
region was amplified by PCR using the primer pairs listed in the
Supporting Table S2. The resulting amplicon was cloned into
pJN105 at the EcoRI and SpeI sites to generate pLsfA. pLsfA and
pJN105 plasmids were introduced into the DlsfA and the C45A
mutants, generating the DlsfA/pJN105, DlsfA/pLsfA, C45A/
pJN105 and C45A/pLsfA strains.
Protein expression and purification
The lsfA or lsfAC45A coding regions were cloned into pProEX-
Hta to overexpress His-LsfA or His-LsfAC45A in E. coli BL21.
Briefly, E. coli cultures were grown in 250 mL of LB at 37uC until
the culture reached an OD600 nm of 0.5. IPTG was added to a final
concentration of 0.6 mM, and the cultures were grown at 30uC for
6 h. Cells were harvested by centrifugation and resuspended in
25 mL lysis buffer (20 mM sodium phosphate pH 7.4, 500 mM
NaCl, 20 mM imidazole, 1 mM PMSF). Cell suspensions were
lysed by ten 15 second sonication cycles in an ice bath. The lysate
was centrifuged at 16000 g for 20 min at 4uC. The recombinant
proteins His-LsfA and His-LsfAC45A were purified using an Ni-
NTA column (Invitrogen) equilibrated with lysis buffer and eluted
with an imidazole gradient (20–1000 mM). The eluted fractions
were analyzed by SDS-PAGE and pooled, and the buffer was
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exchanged using a PD-10 column (GE) equilibrated with
incomplete reaction buffer (20 mM sodium phosphate pH 7.4,
500 mM NaCl). The proteins were concentrated with Centriprep-
Ultracel YM-10.000 MWCO (Millipore). The protein concentra-
tion was determined by UV spectroscopy using an extinction
coefficient of 33920 M21 cm21, calculated as described by Gill
and von Hippel [51], and confirmed using the Bradford reagent
(Sigma-Aldrich) according to the manufacturer’s protocol.
Peroxidase activity determination
The in vitro peroxidase activity was determined using the ferric-
thiocyanate assay [15]. Briefly, 10 mM of purified recombinant
protein was incubated at 37uC in 100 mL of reaction buffer
(20 mM sodium phosphate pH 7.4, 500 mM NaCl, 1 mM DTT,
10 mM DTPA, 10 mM sodium azide) in the presence or absence of
200 mM H2O2. At the times indicated, the reaction was stopped by
the addition of 20 mL of 2 M HCl and incubated for 10 min at
37uC. Then, 100 mL of 2.5 M KSCN, 100 mL of 20 mM FeSO4
and 680 mL of H2O were added to the reaction. The absorbance
was read at 480 nm. As controls, we used the same conditions in
the absence of DTT or without recombinant protein. After the
reaction times, the H2O2 concentration was determined by
comparison with a standard curve with different H2O2 concen-
trations (15.625–1000 mM).
Disk diffusion halo assays
Halo inhibition assays were performed as described before with
modifications [52]. Cultures of P. aeruginosa PA14 and the DlsfA
and C45A mutant and complemented strains were grown
overnight in LB broth. Cultures were diluted into fresh LB broth
to an OD600 nm of 0.1 and grown to an OD600 nm of 1.0. Plate
assays were performed by adding 200 mL of a cell culture to 3 mL
of 0.7% LB soft agar. The agar suspensions were spread on LB
plates. Sterile paper disks (6 mm in diameter) were saturated with
10 mL of 2.5% hydrogen peroxide and placed on the plates, which
were incubated for 16 hours at 37uC. For the complementation
assays, 30 ug/mL gentamicin (to maintain the plasmids) and 0.2%
arabinose (to induce expression from the ara promoter) were
added into the LB.
Cell culture
The macrophage cell line J774 was maintained in R-10 (RPMI
1640 supplemented with 2 mM glutamine, 10% fetal bovine
serum (FBS) and 40 mg/mL gentamicin) at 37uC in 5% CO2.
Macrophages were counted using a Neubauer chamber, and dead
cells were excluded by the trypan blue exclusion assay. Macro-
phages were seeded at 16105 cells/well (96-well plates) or 26106
(6-well plates) in R-10 without antibiotic and primed overnight
with 10 ng/mL IFN-c at 37uC in 5% CO2.
In vitro infection experiments
PA14 and the DlsfA and C45A mutant strains were grown in
LB broth to an OD600 nm of 2.0. The bacteria were diluted in R-10
without antibiotics. Macrophages that had been previously seeded
in 96-well plates were infected at a multiplicity of infection (MOI)
of 10. After 1 hour of infection, the supernatant was removed and
200 mg/mL of gentamicin was added to cell cultures to kill
extracellular bacteria. After 30 minutes the cells were washed once
with PBS and fresh media were added. This point was defined as
time 0 (t = 0 h). To determine the numbers of extracellular
bacteria, the supernatant was collected, serially diluted, the cells
were plated and the CFU were enumerated. To access intracel-
lular bacteria, macrophages were lysed with PBS+0.1% Triton X-
100, the lysates were serially diluted, and the CFU were
determined. Cytotoxicity was measured for samples taken at the
indicated times by quantifying the release of lactate dehydrogenase
(LDH) using the CytoTox 96H Non-Radioactive Cytotoxicity
Assay (Promega) following the manufacturer’s instructions. For
NADPH oxidase inhibition, macrophages were treated with
10 mM DPI (diphenylene iodonium) 4 hours before infection
and the same steps described above were performed. To quantify
TNF-a, macrophages were seeded in six-well plates and infected at
an MOI of 10. For inhibition experiments, where indicated, cells
were pretreated for 4 hours before infection with an NF-kB
inhibitor (10 mM BAY11-7085) or MAPK inhibitors of ERK1/2
(1 mM U0126), p38 (1 mM SB203580), or JNK (1 mM SP600125);
alternatively, the cells were treated with 2 mM NAC. At 3 hours
post-infection, the supernatants were removed, centrifuged and
stored at 220uC. Cytokine quantification was performed by
ELISA (R&D systems) following the manufacturer’s instructions.
Oxidative state evaluation
The macrophage oxidative state was determined as described
previously [53]. Briefly, macrophages were pre-treated with or
without 2 mM NAC for 4 hours before infection. Macrophages
were infected with PA14 or with the DlsfA, C45A or gacA::tn
mutant strains at an MOI of 10. After the indicated time in post-
infection culture medium, the cells were washed with PBS and
then incubated with H2DCFDA (Invitrogen) at a 2.5 mM final
concentration for 30 min at 37uC. Cells were washed with
warmed PBS (37uC), resuspended in cold PBS containing 1%
FBS and analyzed by fluorescence-activated cell sorting (FACS).
Unstained controls were treated similarly. For the baseline
fluorescence control, macrophages were uninfected but stained
according to the above procedure. The mean fluorescence
intensity values were calculated by dividing the values of the
infected macrophages by those of the uninfected control.
Ethics statement
The animal experiments were performed in agreement with the
Ethical Principles in Animal Research adopted by the Conselho
Nacional de Controle da Experimentac¸a˜o Animal (CONCEA)
and in accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the Internal Animal Care
and Use Committee of the Instituto de Quı´mica, Universidade de
Sa˜o Paulo (Nu08/2012).
Animals
Female BALB/c mice (8–12 weeks old) were obtained from the
in-house animal facility (Biote´rio de Produc¸a˜o e Experimentac¸a˜o
da Faculdade de Cieˆncias Farmaceˆuticas e do Instituto de
Quı´mica da Universidade de Sa˜o Paulo). Mice were kept on a
12/12-h light/dark cycle with free access to food and water and
were maintained under specific pathogen-free conditions. All mice
were euthanized in CO2 chamber, and every effort was made to
minimize suffering.
Animal inoculation with bacteria
PA14 and the DlsfA and C45A mutant strains were used for i.t.
inoculation as described before [54], with few modifications.
Bacteria were grown as described above, harvested by centrifu-
gation at 12000 g for 2 min, washed twice in sterile PBS and
resuspended in PBS at a concentration of 26106 bacteria. The
CFU/mL were validated by plating serial dilutions of the
suspensions. Each mouse received 60 mL of a bacterial suspension.
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A ketamine/xylazine mixture was injected i.p. to anesthetize the
mice before surgery. A midventral incision was made, and the
trachea was exposed. The bacterial suspension was inoculated i.t.
Controls were inoculated i.t. with 60 mL sterile PBS.
In vivo CFU determination
At 24 hours after infection, the lungs, spleen and liver were
harvested for CFU and cytokine measurements. The tissues were
homogenized in 1 mL PBS for the lung and spleen and in 2 mL
PBS for the liver. The supernatants were collected, and the CFUs
were assayed by serial dilution and plating on LB plates. For
cytokine measurements, the lung tissues were homogenized, and
the supernatants were centrifuged at 12000 g for 10 min at 4uC.
The cytokines TNF-a, IFN-c and IL-10 were quantified by ELISA
(R&D systems), following the manufacturer’s instructions.
FACS
At 24 hours after infection, the lungs were harvested, minced
and digested with collagenase for 30 min at 37uC. The RBCs were
lysed by adding NH4Cl lysing buffer. The cells were resuspended
in PBS with 3% FBS and stained with different combinations of
conjugated antibodies, including F4/80-PECy5 (BM8), CD11c-
FITC (HL3), CD11b-PE (M1/70) and Ly6G/Ly6C-APC (RB6-
8C5), followed by incubation for 20 min on ice. Finally, the cells
were washed and resuspended for flow cytometry analysis. FlowJo
software (Tree Star) was used to analyze the data.
Myeloperoxidase activity assay
The myeloperoxidase activity assay was performed as previously
described with a few modifications [55,56]. The animals were
infected as described above, and the lungs were harvested, lysed
mechanically in the presence of 50 mM sodium phosphate
pH 5.4, 5 mM EDTA and 0.5% cetyltrimethylammonium bro-
mide, ultrasonicated and centrifuged. The supernatant (50 mL)
was mixed with an equal volume of 3 mM 3,39,5,59-tetramethyl-
benzidine dihydrochloride (TMB) for 2 minutes. The reaction was
stopped by the addition of 25 mL of 2M H2SO4. The optical
density (OD) was measured at 450 nm.
Survival
After i.t. infection with wild-type PA14 or the DlsfA or C45A
strains, the treated (N = 8) and control (N = 3) groups were
observed for survival. All deaths reported were from moribund/
euthanized mice. Mice with labored or rapid breathing, decreased
motility, ruffled or abnormal-looking fur or other obvious signs of
distress were considered to be moribund as described before [57].
Statistical analyses
Prism 5 (GraphPad Inc.) was used for all statistical analyses.
Kaplan-Meier survival curves were plotted, and significance was
calculated using the log-rank test. The data were compared using
the one-way or two-way analysis of variance (ANOVA) followed
by Bonferroni’s multiple comparison test.
Supporting Information
Figure S1 Multiple sequence alignment of 1-Cys Prxs.
ClustalW alignment of 1-Cys Prxs from different species. The
conserved Prx6 motifs are boxed; the catalytic Cys is highlighted in
green, and the lipase motif in blue. Sequences were obtained from
GenBank. The GI numbers are: GI:116051470, GI:78065379,
GI:107021887, GI:53720358, GI:4758638, GI:3219774,
GI:82540481, GI:160877634, GI:6319407, GI:85093072,
GI:70983971, GI:152986639, GI:161525740, GI:33592121,
GI:15598646, GI:431800278, GI:104779502 and GI:50285063.
(DOCX)
Figure S2 Lack of LsfA does not impair bacterial growth
in liquid cultures and in biofilms. PA14 or the DlsfA or
C45A mutant strains were grown in LB (A) or M63 minimal
medium (B) at 37uC, and data were recorded in a SpectraMax
Paradigm apparatus. Data are representative of triplicate exper-
iments. In (C), cultures were grown in LB without shaking in glass
tubes for 16 h, the tubes were washed and the adhered cells
stained with crystal violet.
(DOCX)
Figure S3 Complementation of the lsfA and C45A
sensitivity to H2O2. Plasmids pJN105 (control) or pLsfA
(pJN105 containing the wild-type lsfA gene under an arabinose
inducible promoter) were introduced in the lsfA and C45A mutant
strains and the resulting clones were seeded on LB containing 0.2%
arabinose and 30 mg/mL gentamicin. Filter discs containing 2.5%
H2O2 were placed on top of the agar, the plates were incubated
overnight at 37uC and the haloes were measured. The numbers
inside the plates refer to the diameter of the haloes6 SD. The figure
shows one representative experiment from duplicate assays.
(DOCX)
Figure S4 The wild-type strain and lsfA mutants show
same levels of macrophages cytotoxicity. J774 macrophag-
es were incubated with P. aeruginosa PA14 or the DlsfA or C45A
mutants at an MOI of 10. At the indicated time points, the
supernatants were collected and diluted, the cells were washed
with PBS and R-10 containing 200 mg/mL gentamicin was added
to the wells for 30 min, cells were washed and incubated in R-10.
At the indicated time points, lactate dehydrogenase (LDH) release
was determined as a measure of macrophage death. Data are the
means 6 SD from at least three independent experiments
performed in triplicate.
(DOCX)
Figure S5 NAC reduces macrophage oxidative stress in
C45A and PA14-infected macrophages. Macrophages pre-
treated with 2 mM NAC for 4 hours (grey bars) were infected with
PA14 or with the C45A mutant strains at an MOI of 10. A control
group was not incubated with NAC (white bars). After the
indicated times post-infection, the cells were washed with PBS,
incubated with 2.5 mM H2DCFDA for 30 min at 37uC, washed
again with warmed PBS (37uC), resuspended in cold PBS
containing 1% FBS and analyzed by fluorescence-activated cell
sorting (FACS). Unstained controls were treated similarly. For the
baseline fluorescence control, macrophages were uninfected but
stained. The mean fluorescence intensity values were calculated by
dividing the values of the infected macrophages by those of the
uninfected control.
(DOCX)
Figure S6 IL-10 production in P. aeruginosa-infected
mice is not affected by a mutation in lsfA. BALB/c mice
were infected i.t. with 26106 bacteria of the wild-type strain PA14
or the C45A mutant. The infected animals and controls (n = 3)
were sacrificed 24 hours post-infection, the lungs were macerated,
and the IL-10 concentrations were determined by ELISA. Data
are the means 6 SD from at least three independent experiments
performed in triplicate.
(DOCX)
Table S1 Strains and plasmids used in this study.
(DOCX)
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